Font Size:
a
A
A
Keyword [pathological complete response rate]
Result: 1 - 2 | Page: 1 of 1
1.
Efficacy Evaluation Of Neoadjuvant Chemotherapy For TEC Regimen In HER-2 Negative Breast Cancer
2.
Efficacy And Influencing Factors Of Pertuzumab Combined With Trastuzumab In The Neoadjuvant Therapy Of HERT-2 Positive Breast Cancer
<<First
<Prev Next>
Last>>
Jump to
